Cardiovascular Pharmacology

Cardiovascular Pharmacology deals with the study of the effect of drugs upon the heart or the circulatory system. Cardiovascular diseases are a leading cause of hospitalizations and death in the whole world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Cardiovascular Pharmacology and Therapeutics will focus primarily on drugs used in the treatment of cardiovascular disease, both current drug classes and those in development. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development.

    Related Conference of Cardiovascular Pharmacology

    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Cardiovascular Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in